Phase 2CompletedAge-related condition
Evaluation of BTV100 in Subjects With Dry Eye Disease
A Phase 2, Double-Masked, Randomized, Vehicle-controlled Trial Evaluating the Efficacy and Safety of Cevimeline Ophthalmic Solution Compared to Vehicle in Subjects With Dry Eye Disease
- Sponsor
- BioTheraVision, Inc. (Industry)
- Enrolment
- 123 enrolled
- Conditions
- Dry Eye
- Interventions
- BTV100 Low dose; BTV100 Mid dose; BTV100 High dose; Placebo
- Ages
- adults, older adults
- Registry
- NCT06543303
Full record on ClinicalTrials.gov
From the registry
This study will be a randomized, vehicle-controlled, double-masked, multiple-dose, parallel-group study to evaluate the efficacy, safety and tolerability of repeat dosing of Cevimeline Ophthalmic Solution compared to the vehicle in subjects with Dry Eye Disease (DED).
Primary outcomes
- Schirmer test
History
Last registry update
Primary completion
Started
Registered